- Trials with a EudraCT protocol (41)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
41 result(s) found for: Energy Intake.
Displaying page 1 of 3.
EudraCT Number: 2005-002080-88 | Sponsor Protocol Number: NA | Start Date*: 2005-09-13 | |||||||||||
Sponsor Name:Aintree Hospitals NHS Trust and University of Liverpool | |||||||||||||
Full Title: A double−blind, placebo−controlled crossover trial to quantify the effects of sibutramine on energy intake and energy expenditure in obese subjects during a test meal | |||||||||||||
Medical condition: Obesity defined as BMI > 30 kg /m2 | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000530-54 | Sponsor Protocol Number: VS56151/17000277 | Start Date*: 2018-01-16 | |||||||||||||||||||||
Sponsor Name:University of Copenhagen | |||||||||||||||||||||||
Full Title: The effect of cannibinols in patients with pancreatic cancer in the palliative state | |||||||||||||||||||||||
Medical condition: Pancreatic cancer | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001380-13 | Sponsor Protocol Number: PROPADB-01 | Start Date*: 2014-08-08 |
Sponsor Name:Abelardo Garcia De Lorenzo / Teresa Nuñez-Villaveiran | ||
Full Title: Effects of the treatment with propranolol in the burnt adult intubated patient with sinusal tachycardia induced by burns. | ||
Medical condition: BURNT-INDUCED SINUSAL TACHYCARDIA | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002487-41 | Sponsor Protocol Number: GLY-321-2017 | Start Date*: 2018-01-31 | |||||||||||
Sponsor Name:GLyPharma Therapeutic Inc. (a wholly owned subsidiary of VectivBio Holding AG) | |||||||||||||
Full Title: A Phase Ib/IIa open-label, repeated dose, metabolic balance study of FE 203799 in patients with short bowel syndrome | |||||||||||||
Medical condition: Short bowel syndrome (SBS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001972-46 | Sponsor Protocol Number: SKNt-001-CP4 | Start Date*: 2019-05-14 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: Reaching Protein Target with SmofKabiven® extra Nitrogen Versus Olimel N9E: A Prospective, Randomised, Active-controlled, Patient-blinded, Multicentre Clinical Trial During the Early Phase of Acute... | |||||||||||||
Medical condition: Parenteral nutrition (PN) when oral or enteral nutrition (ON or EN) is impossible, insufficient, or contraindicated in the early phase of critical illness | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) DE (Prematurely Ended) PL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006440-55 | Sponsor Protocol Number: Amino Acid 01/2007 | Start Date*: 2007-08-27 | |||||||||||
Sponsor Name:University Childrin's Hospital | |||||||||||||
Full Title: Effect on metabolic acidosis due to hyperammonemia of high versus low intake of amino acid in VLBW infants. | |||||||||||||
Medical condition: At birth, a VLBW infant is abruptly disconnected from the ideal source of parenteral nutrition - the placenta. If the goal of post-natal nutrition in the VLBW infant is to mimic in utero nutrition.... | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001220-19 | Sponsor Protocol Number: D5670C00021 | Start Date*: 2018-08-07 | |||||||||||
Sponsor Name:MedImmune Limited, a wholly owned subsidiary of AstraZeneca | |||||||||||||
Full Title: An Exploratory Phase 2a, Randomised, Double-blind, Placebo-controlled Study to Evaluate the Effect of MEDI0382 on Energy Balance in Overweight and Obese Subjects with Type 2 Diabetes Mellitus | |||||||||||||
Medical condition: Type 2 Diabetes Mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000778-46 | Sponsor Protocol Number: LiBiDi-EK314/11 | Start Date*: 2013-01-17 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Forschungszentrum Jülich GmbH | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Elucidation of Lithium Working Mechanism in Bipolar Disorder by means of Multi Modal Brain Imaging (LiBiDi) | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Healthy volunteers Bipolar patients type 1 | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000476-14 | Sponsor Protocol Number: TCI_BRIVA | Start Date*: 2013-05-07 | |||||||||||
Sponsor Name:LANDSTINGET I ÖSTERGÖTLAND | |||||||||||||
Full Title: TARGET-CONTROLLED INFUSION (TCI) WITH PROPOFOL AND REMIFENTANIL AS ANALGO-SEDATION IN WOUND CARE IN PATIENTS WITH BURNS | |||||||||||||
Medical condition: Burn patients who need analgo-sedation during wound care. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001569-16 | Sponsor Protocol Number: VITPED/P01/04/MU.UK | Start Date*: 2006-07-17 |
Sponsor Name:BAXTER SAS R&D Parenteral Nutrition | ||
Full Title: EFFICIENCY AND SAFETY OF CLINAVIT PAEDIATRIC AT A WEIGHT DEPENDANT DOSE ADMINISTERED DAILY FOR 5 CONTINUOUS DAYS ON 4 VITAMINS BLOOD LEVEL IN NEONATES AND CHILDREN UP TO 11 YEARS OF AGE RECEIVING P... | ||
Medical condition: No special medical condition but Patient requiring for any underlying pathology at least 5 days of total parenteral nutrition, representing at least 90% of their total energy needs | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000841-28 | Sponsor Protocol Number: DC2017DECREASE01 | Start Date*: 2017-08-14 |
Sponsor Name:VU University Medical Center | ||
Full Title: Combined effects of SGLT2 inhibition and GLP-1 receptor agonism on food intake, body weight and central satiety and reward circuits in obese T2DM patients | ||
Medical condition: Type 2 diabetes mellitus Obesity | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-005327-16 | Sponsor Protocol Number: | Start Date*: 2014-07-15 | |||||||||||
Sponsor Name:The University of Edinburgh [...] | |||||||||||||
Full Title: A Randomized Open Label Pilot Study to Compare Targinact vs. Oxycodone in Early Return of Gastrointestinal Function after Colorectal Surgery | |||||||||||||
Medical condition: Post-operative pain | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002826-38 | Sponsor Protocol Number: ZP1848-15073 | Start Date*: 2016-01-28 | |||||||||||
Sponsor Name:Zealand Pharma A/S | |||||||||||||
Full Title: A phase 2 trial testing ZP1848 in patients with SBS | |||||||||||||
Medical condition: Short Bowel Syndrome (SBS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005325-67 | Sponsor Protocol Number: 1239102 | Start Date*: 2013-04-30 | |||||||||||
Sponsor Name:Centre Hospitalier de Toulouse | |||||||||||||
Full Title: Evaluation of tolerance, suckling and food intake after repeated nasals administrations of Oxytocin in PWS infants | |||||||||||||
Medical condition: Prader Willi Syndrom | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003060-59 | Sponsor Protocol Number: NN304-1761 | Start Date*: 2007-03-16 | |||||||||||
Sponsor Name:Novo Nordisk Limited | |||||||||||||
Full Title: A 32 week, national, single-centre, open-labelled, randomised, cross-over trial comparing energy expenditure with insulin detemir versus NPH insulin using a basal-bolus regimen with insulin aspart ... | |||||||||||||
Medical condition: Type 1 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005194-27 | Sponsor Protocol Number: ZP1848-20060 | Start Date*: 2021-06-30 | |||||||||||
Sponsor Name:Zealand Pharma A/S | |||||||||||||
Full Title: A Single-Center Phase 3b Trial Investigating the Long-term Effect on Intestinal Absorption, Nutritional Status and Long-Term Safety of treatment with Glepaglutide in Patients with Short Bowel Syndr... | |||||||||||||
Medical condition: Short bowel syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-005547-17 | Sponsor Protocol Number: RHMNUT0048 | Start Date*: 2010-01-28 |
Sponsor Name:Southampton University Hospital NHS Trust | ||
Full Title: Refeeding risks in patients requiring nutrition support. A twin centre double-blind randomised controlled trial of parenteral nutrition support. | ||
Medical condition: Patients who have a non-functioning gastrointestinal tract require artifical intravenous nutrition. This is usally a result recent surgery or sepsis causing a reversible short term paralysis of th... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000082-72 | Sponsor Protocol Number: RC-P0054 | Start Date*: 2019-01-03 | |||||||||||
Sponsor Name:Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL) | |||||||||||||
Full Title: Study of the communication of the hypothalamus with the periphery: impact of metformin on leptin transport in the cerebrospinal fluid of obese patients. A monocentric prospective study | |||||||||||||
Medical condition: OBESITY (BMI > 30) | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001559-30 | Sponsor Protocol Number: SMKV-013-CP4 | Start Date*: 2017-09-13 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: Efficacy of long-term parenteral nutrition with SmofKabiven® E concomitant to chemo- and/or immunotherapy: A prospective, randomised, controlled, open, multicentre, two-stage, adaptive clinical tri... | |||||||||||||
Medical condition: Metastatic Non-Small Cell Lung Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001019-19 | Sponsor Protocol Number: UX007 | Start Date*: 2016-06-27 |
Sponsor Name:LIEGE University Hospital | ||
Full Title: A pilot trial of triheptanoin for the preventive treatment of migraine | ||
Medical condition: Migraine | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.